Skip to main navigation Skip to search Skip to main content

Casein kinase II (CK2) as a therapeutic target for hematological malignancies

  • Chandrika Gowda
  • , Mansi Sachdev
  • , Sunil Muthusami
  • , Malika Kapadia
  • , Lidija Petrovic-Dovat
  • , Melanie Hartman
  • , Yali Ding
  • , Chunhua Song
  • , Jonathon L. Payne
  • , Bi Hua Tan
  • , Sinisa Dovat

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)95-107
Number of pages13
JournalCurrent Pharmaceutical Design
Volume23
Issue number1
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

ASJC Scopus Subject Areas

  • Pharmacology
  • Drug Discovery

Keywords

  • CK2
  • CX-4945
  • Casein kinase II
  • Ikaros
  • Leukemia
  • PI3K pathway
  • PP1
  • Phosphorylation
  • Protein phosphatase 1
  • Targeted therapy
  • Casein Kinase II/antagonists & inhibitors
  • Humans
  • Protein Kinase Inhibitors/chemistry
  • Antineoplastic Agents/chemistry
  • Hematologic Neoplasms/drug therapy
  • Animals

Cite this